Miodrag Gužvić,Simon Engelmann,Maximilian Burger et al.
Miodrag Gužvić et al.
Molecular analysis of disseminated tumour cells (DTC) may aid in predicting the course of the disease and response to therapies in individual patients. It has been shown in bladder cancer and many other cancer types that the presence of dis...
[Organoids as a milestone on the way to personalized treatment of urothelial carcinoma: a systematic review] [0.03%]
[类器官在尿路上皮癌个性化治疗之路上的里程碑：系统性综述]
Michael Karl Melzer,Viktor Zehe,Friedemann Zengerling et al.
Michael Karl Melzer et al.
Background: The treatment options for locally advanced and metastatic urothelial carcinoma (UC) are currently limited to established chemotherapy and immunotherapy protocols. Targeted treatment is so far restricted to a s...
[Patient-derived microtumors : Potential for therapeutic response prediction-a case study] [0.03%]
[患者来源的微肿瘤：预测治疗反应的潜力-案例研究]
Eva Erne,Nicole Anderle,Christian Schmees et al.
Eva Erne et al.
Background: In view of continued development of new oncological approaches, there is a high demand for personalized tumor therapy. However, fast and effective functional platforms for the prediction of individual patient ...
[Tebipenem pivoxil : Oral carbapenem for treatment of complicated urinary tract infections] [0.03%]
特比培南酯：口服碳青霉烯类药物治疗复杂性尿路感染
Jens Rosellen,Florian Wagenlehner
Jens Rosellen
[Immunological biomarker research in uro-oncology-using the example of urothelial cancer] [0.03%]
[泌尿系统肿瘤免疫生物标志物研究——以尿路上皮癌为例]
Markus Eckstein
Markus Eckstein
The most common malignant tumor of the urinary tract system is urothelial carcinoma (UC). With the introduction of novel immunologic therapy options in both metastatic and localized settings, the exploration of immunologic biomarkers to pre...
C Schüttler,R Jahns,U Prokosch et al.
C Schüttler et al.
When we think of medical research, one intuitively associates it with the analysis of study data collected for a specific research question or with the secondary use of patient data from routine care. However, these are not the only sources...
Christoph Becker,Maximilian Burger,Axel Haferkamp
Christoph Becker
[Erratum to: Extended vs. standard lymphadenectomy for the treatment of urothelial carcinoma of the bladder in patients undergoing radical cystectomy] [0.03%]
[尿路上皮癌根治性膀胱切除术中扩大淋巴结清扫与常规淋巴结清扫的差异——对“BLADDERCAN试验：一项随机对照研究，评估T1-3N0M0期尿路上皮癌患者行根治性膀胱切除时扩大盆腔淋巴结清扫与标准盆腔淋巴结清扫在总生存率、无病生存率及生活质量方面效果”的勘误]
Laila Schneidewind,Bernhard Kiss
Laila Schneidewind
Published Erratum
Urologie (Heidelberg, Germany). 2023 Dec;62(12):1331. DOI:10.1007/s00120-022-01865-w 2023
[Peri-interventional management of platelet aggregation inhibition and anticoagulation in urology] [0.03%]
[泌尿外科血小板聚集抑制和抗凝的 peri-操作管理]
Bernd Krabbe,Katharina Beckmann,Laura-Maria Krabbe
Bernd Krabbe
Perioperative management of anticoagulation in patients receiving long-term anticoagulation or platelet aggregation inhibitors requires an individual consideration of competing risks. If the risk for bleeding is low, anticoagulation can oft...